Article Details
Retrieved on: 2021-02-11 22:16:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Court to invalidate Amgen's patent claims directed to PCSK9 antibodies ... technology that yields optimized fully-human monoclonal antibodies.
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here